Compare Stocks Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities. Stocks to Compare Sections All Sections Selected Performance Chart Price & Volume MarketRank Analyst Ratings Sales & Book Value Profitability & Earnings Dividends Debt Ownership Miscellaneous Headlines About Compare NASDAQ:ASTHNASDAQ:CNDTNYSE:GBNASDAQ:GDRX On This Page Performance ChartPrice & VolumeMarketRank™Analyst RatingsSales & Book ValueProfitability & EarningsDividendsDebtOwnershipMiscellaneousHeadlinesAbout Comparison Ideas Stock Ideas Comparative Price Performance Over Time1 day7 days30 days90 days365 daysCompare Price & VolumeCompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's VolumeASTHAstrana Health$26.70+6.5%$27.62$23.12▼$63.20$1.41B0.85293,638 shs330,721 shsCNDTConduent$2.63+1.9%$2.32$1.90▼$4.90$417.52M1.541.16 million shs889,692 shsGBGlobal Blue Group$7.49+0.5%$7.43$4.29▼$8.00$1.49B0.44227,268 shs83,975 shsGDRXGoodRx$5.07+8.1%$4.29$3.68▼$9.26$1.68B1.161.41 million shs2.37 million shs20 High-Yield Dividend Stocks that Could Ruin Your RetirementAlmost everyone loves strong dividend-paying stocks, but high yields can signal danger. Discover 20 high-yield dividend stocks paying an unsustainably large percentage of their earnings. Enter your email to get this report and avoid a high-yield dividend trap.Get This Free ReportCompare Price PerformanceCompany1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year PerformanceASTHAstrana Health+6.50%+8.27%+9.92%-13.28%-34.35%CNDTConduent+1.94%-3.31%+21.76%-9.31%-18.83%GBGlobal Blue Group+0.40%+0.34%+0.81%+1.35%+52.44%GDRXGoodRx+8.10%+15.49%+35.56%+11.67%-33.46%Compare MarketRank™CompanyOverall ScoreAnalyst's OpinionShort Interest ScoreDividend StrengthESG ScoreNews and Social Media SentimentCompany OwnershipEarnings & ValuationASTHAstrana Health2.8955 of 5 stars3.32.00.00.02.90.81.9CNDTConduent3.9177 of 5 stars0.05.00.00.03.43.32.5GBGlobal Blue Group1.2796 of 5 stars1.03.00.00.01.11.72.5GDRXGoodRx3.3946 of 5 stars3.32.00.00.03.32.51.9Compare Analyst ForecastsCompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current PriceASTHAstrana Health 2.67Moderate Buy$53.2999.57% UpsideCNDTConduent 0.00N/AN/AN/AGBGlobal Blue Group 2.00Hold$6.00-19.84% DownsideGDRXGoodRx 2.64Moderate Buy$6.5529.10% UpsideCurrent Analyst Ratings BreakdownLatest CNDT, GDRX, ASTH, and GB Analyst RatingsDateCompanyBrokerageActionRatingPrice TargetDetails5/13/2025GDRXGoodRxUBS GroupSubscribe to MarketBeat All Access for the recommendation accuracy ratingLower Price TargetNeutral ➝ Neutral$6.00 ➝ $5.255/9/2025GDRXGoodRxThe Goldman Sachs GroupSubscribe to MarketBeat All Access for the recommendation accuracy ratingLower Price TargetNeutral ➝ Neutral$6.00 ➝ $5.004/29/2025GDRXGoodRxWells Fargo & CompanySubscribe to MarketBeat All Access for the recommendation accuracy ratingLower Price TargetOverweight ➝ Overweight$8.00 ➝ $7.004/10/2025GDRXGoodRxTruist FinancialSubscribe to MarketBeat All Access for the recommendation accuracy ratingLower Price TargetHold ➝ Hold$6.50 ➝ $5.504/1/2025ASTHAstrana HealthBarclaysSubscribe to MarketBeat All Access for the recommendation accuracy ratingInitiated CoverageEqual Weight$36.00(Data available from 6/25/2022 forward. View 10+ years of historical ratings with our analyst ratings screener.)Compare Sales & Book ValueCompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/BookASTHAstrana Health$2.03B0.74$1.58 per share16.89$14.59 per share1.83CNDTConduent$3.36B0.13$0.76 per share3.44$5.27 per share0.50GBGlobal Blue Group$545.29M2.74$0.64 per share11.67$0.78 per share9.60GDRXGoodRx$792.32M2.29$0.34 per share14.74$1.89 per share2.68Compare Profitability & EarningsCompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings DateASTHAstrana Health$43.15M$0.7237.0818.941.351.56%4.90%2.68%8/6/2025 (Estimated)CNDTConduent$426M$1.371.92N/AN/A8.66%-11.28%-3.45%8/6/2025 (Estimated)GBGlobal Blue Group$90.58M$0.3720.2322.68N/A16.56%45.20%4.69%8/27/2025 (Estimated)GDRXGoodRx$16.39M$0.0863.3828.172.093.57%7.85%3.91%8/6/2025 (Estimated)Latest CNDT, GDRX, ASTH, and GB EarningsDateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails6/4/2025Q4 2025GBGlobal Blue Group$0.04$0.06+$0.02$0.05$130.33 million$137.18 million5/8/2025Q1 2025ASTHAstrana Health$0.23$0.14-$0.09$0.14$628.11 million$620.39 million5/7/2025Q1 2025CNDTConduent-$0.19-$0.13+$0.06-$0.33$776.00 million$751.00 million5/7/2025Q1 2025GDRXGoodRx$0.04$0.09+$0.05$0.03$202.25 million$202.97 millionCompare DividendsCompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive GrowthASTHAstrana HealthN/AN/AN/AN/AN/ACNDTConduentN/AN/AN/AN/AN/AGBGlobal Blue GroupN/AN/AN/AN/AN/AGDRXGoodRxN/AN/AN/AN/AN/ACompare DebtCompanyDebt-to-Equity RatioCurrent RatioQuick RatioASTHAstrana Health0.541.701.70CNDTConduent0.781.641.64GBGlobal Blue Group3.691.011.01GDRXGoodRx0.745.235.23Compare OwnershipInstitutional OwnershipCompanyInstitutional OwnershipASTHAstrana Health52.77%CNDTConduent77.28%GBGlobal Blue Group89.66%GDRXGoodRx63.77%Insider OwnershipCompanyInsider OwnershipASTHAstrana Health8.46%CNDTConduent2.98%GBGlobal Blue GroupN/AGDRXGoodRx4.17%Compare Miscellaneous StatsCompanyEmployeesShares OutstandingFree FloatOptionableASTHAstrana Health1,90056.06 million51.32 millionOptionableCNDTConduent56,000161.83 million157.01 millionOptionableGBGlobal Blue Group2,160199.57 millionN/AOptionableGDRXGoodRx950357.17 million342.28 millionOptionableCNDT, GDRX, ASTH, and GB HeadlinesRecent News About These CompaniesCWA Asset Management Group LLC Buys Shares of 66,275 GoodRx Holdings, Inc. (NASDAQ:GDRX)June 22 at 3:50 AM | marketbeat.comGoodRx (GDRX) Launches a New Subscription Service for Erectile Dysfunction TreatmentJune 15, 2025 | finance.yahoo.comGoodRx Holdings, Inc. (NASDAQ:GDRX) Given Consensus Recommendation of "Moderate Buy" by AnalystsJune 15, 2025 | marketbeat.comAnalysts’ Opinions Are Mixed on These Healthcare Stocks: GoodRx Holdings (GDRX) and Insmed (INSM)June 13, 2025 | theglobeandmail.comGDRX Q1 Earnings Call: Management Focuses on Pharmacy Partnerships and Marketplace EvolutionJune 12, 2025 | msn.comUBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC Purchases 61,924 Shares of GoodRx Holdings, Inc. (NASDAQ:GDRX)June 12, 2025 | marketbeat.comGoodRx (GDRX): Buy, Sell, or Hold Post Q1 Earnings?June 10, 2025 | msn.comGoodRx (NASDAQ:GDRX) Shares Gap Up - Here's WhyJune 10, 2025 | marketbeat.comGoodRx Holdings, Inc. (NASDAQ:GDRX) Major Shareholder Equity Vii L.P. Spectrum Sells 10,677 SharesJune 10, 2025 | insidertrades.comGoodRx Holdings, Inc. (NASDAQ:GDRX) Shares Sold by Bank of America Corp DEJune 10, 2025 | marketbeat.comInsider Selling: GoodRx Holdings, Inc. (NASDAQ:GDRX) Major Shareholder Sells 10,677 Shares of StockJune 9, 2025 | marketbeat.comGoodRx Launches Community Link to Offer Independent Pharmacies Cost-Plus PricingJune 9, 2025 | businesswire.comGoodRx: Stabilizing Revenue Amid Healthy Profit GainsJune 6, 2025 | seekingalpha.comGoodRx (NASDAQ:GDRX) Shares Up 5.9% - Still a Buy?June 5, 2025 | marketbeat.comGoodRx Open Sources Lifecycle to Support Innovation in Software Development Velocity and Developer ProductivityJune 5, 2025 | businesswire.comJim Cramer Holds Back on GoodRx (GDRX)June 5, 2025 | insidermonkey.comTwo Sigma Investments LP Grows Position in GoodRx Holdings, Inc. (NASDAQ:GDRX)May 31, 2025 | marketbeat.comTwo Sigma Advisers LP Increases Position in GoodRx Holdings, Inc. (NASDAQ:GDRX)May 28, 2025 | marketbeat.comMillennium Management LLC Lowers Position in GoodRx Holdings, Inc. (NASDAQ:GDRX)May 26, 2025 | marketbeat.comGoodRx to Launch Direct Contracting for Independent Community PharmaciesMay 22, 2025 | standard-journal.comGoodRx Offers Value Proposition As Pharmacy Costs Shifts To Consumers: AnalystMay 19, 2025 | benzinga.comNew MarketBeat Followers Over TimeMedia Sentiment Over TimeCNDT, GDRX, ASTH, and GB Company DescriptionsAstrana Health NASDAQ:ASTH$26.70 +1.63 (+6.50%) Closing price 06/24/2025 04:00 PM EasternExtended Trading$26.74 +0.04 (+0.15%) As of 04:26 AM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.Astrana Health, Inc., Inc., a physician-centric technology-powered healthcare management company, provides medical care services in the United States. It operates through three segments: Care Partners, Care Delivery, and Care Enablement. The company is leveraging its proprietary population health management and healthcare delivery platform, operates an integrated, value-based healthcare model which empowers the providers in its network to deliver care to its patients. It offers care coordination services to patients, families, primary care physicians, specialists, acute care hospitals, alternative sites of inpatient care, physician groups, and health plans. The company's physician network consists of primary care physicians, specialist physicians and extenders, and hospitalists. It serves patients, primarily covered by private or public insurance, such as Medicare, Medicaid, and health maintenance organization plans; and non-insured patients. The company was formerly known as Apollo Medical Holdings, Inc. and changed its name to Astrana Health, Inc. in February 2024. Astrana Health, Inc. was incorporated in 1985 and is headquartered in Alhambra, California.Conduent NASDAQ:CNDT$2.63 +0.05 (+1.94%) Closing price 06/24/2025 04:00 PM EasternExtended Trading$2.60 -0.02 (-0.95%) As of 06/24/2025 07:50 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.Conduent Incorporated provides digital business solutions and services for the commercial, government, and transportation spectrum in the United States, Europe, and internationally. It operates through three segments: Commercial, Government Services, and Transportation. The Commercial segment offers business process services and customized solutions to clients in various industries; and customer experience management, business operations, healthcare claims and administration, and human capital solutions. The Government segment provides government-centric business process services to the United States federal, state, local, and foreign governments for public assistance, program administration, transaction processing, and payment services; and digital payments, child support payments, government healthcare, and eligibility and enrollment solutions. The Transportation segment offers systems, support, and revenue-generating solutions to government transportation agency clients; and public safety, mobility, and digital payment solutions. This segment also provides electronic tolling, urban congestion management, and mileage-based user solutions; transit solutions; citation and permit administration, parking enforcement, and curbside demand management solutions; and computer-aided dispatch/automatic vehicle location solutions. Conduent Incorporated was founded in 2016 and is headquartered in Florham Park, New Jersey.Global Blue Group NYSE:GB$7.48 +0.04 (+0.47%) Closing price 06/24/2025 03:59 PM EasternExtended Trading$7.48 0.00 (0.00%) As of 06/24/2025 07:09 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.Global Blue Group Holding AG, together with its subsidiaries, provides technology-enabled transaction processing services for merchants, banks, acquirers, governments, and travelers in Europe, the Asia Pacific, and internationally. The company operates in three segments: Tax Free Shopping Technology Solutions (TFSS), Added-Value Payment Solutions (AVPS), and Retail Tech Solutions (RTS). It offers TFSS, a value added tax (VAT) refund service that allows eligible shoppers to reclaim VAT on goods purchased outside of their home country; and intelligence and marketing services. The company also provides AVPS, a service which enables customers to pay in their choice of preferred currency, home or destination, and at the point of sale (POS) when shopping outside of their home country under the Dynamic Currency Choice and Currency Select brands. In addition, it offers currency conversion services for POS, e-commerce return solutions, dynamic currency conversion (DCC) services, and DCC services at ATMs, as well as multi-currency processing services for online retailers. Further, the company provides ZigZag, a technology platform that fully digitalizes the eCommerce returns experience and enhances the process for both retailers and consumers; Yocuda that enables retailers to send digital receipts to their customers; and ShipUp, a post-purchase engagement solution for online purchases enabling brands to deliver seamless, proactive, and branded post-purchase communication. Global Blue Group Holding AG was founded in 1980 and is headquartered in Wangen-Brüttisellen, Switzerland.GoodRx NASDAQ:GDRX$5.07 +0.38 (+8.10%) Closing price 06/24/2025 04:00 PM EasternExtended Trading$5.05 -0.02 (-0.39%) As of 06/24/2025 07:57 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.GoodRx Holdings, Inc., together with its subsidiaries, offers information and tools that enable consumers to compare prices and save on their prescription drug purchases in the United States. The company operates a price comparison platform that provides consumers with curated, geographically relevant prescription pricing, and access to negotiated prices. It also offers other healthcare products and services, including subscriptions, and pharma manufacturer solutions, as well as telehealth services through the GoodRx Care platform. It serves pharmacy benefit managers who manage formularies and prescription transactions, including establishing pricing between consumers and pharmacies. The company was founded in 2011 and is headquartered in Santa Monica, California. More Stock Comparisions from MarketBeat Stock Comparison Ideas (A-K)5GAgricultureAirlineAmerica FirstApparelArtificial IntelligenceAutomotiveBankBiotechBitcoinBlockchainBlue ChipCanadianCannabisCasinoChatGPTChineseCloud StorageCryptocurrencyCybersecurityDefenseDividendDow 30EcommerceElectric VehiclesEnergyEntertainmenteSportsEV ChargingFertilizerGoldGroceryGrowthHealthcareHigh DividendHotelStock Comparison Ideas (L-Z)Large CapLeisureLithiumMagnificent SevenMega CapMemeMetaverseMid CapMiningMusic IndustryNanotechnologyNFTNuclear EnergyOilPharmaceuticalQuantum ComputingRenewable EnergyRestaurantRetailSemiconductorSocial MediaSolarSpaceTechnologyTelecomToyUtilityVideo GameVirtual RealityWallStreetBets More Stock Ideas from MarketBeat Stock Lists 5G Stocks Biotech Stocks Blue Chip Stocks DOW 30 Stocks FAANG Stocks Gold Stocks Large Cap Stocks Lumber Stocks Marijuana Stocks Micro Cap Stocks Oil Stocks REITs Small Cap Stocks SPACs Travel Stocks Trillion Dollar Stocks Water Stocks Warren Buffett Stocks Low Priced Stocks Penny Stock List Popular Penny Stocks Top Stocks Today Stocks on Sale Stocks Under $0.05 Stocks Under $0.10 Stocks Under $0.25 Stocks Under $0.50 Stocks Under $1 Stocks Under $2 Stocks Under $3 Stocks Under $5 Stocks Under $10 Stocks Under $20 Stocks Under $30 Stocks Under $50 Stocks By Exchange NASDAQ Stocks NYSE Stocks NYSEAMERICAN Stocks NYSEARCA Stocks NYSEMKT Stocks OTCMKTS Stocks TSX Stocks TSXV Stocks LSE Stocks BATS Stocks Latest Stock Ideas 3 Hot Trades for Insiders, But Are They Good Buys for Investors? Why Qualcomm’s Latest Price Target Can't Be Ignored Texas Instruments Stock: Congress Likes It, Should You Too? Geospace Stock Skyrockets After Major Petrobras Contract Analyst Sees Meta Hitting $800: What May Lead Shares to New Highs CrowdStrike Eyes Breakout as Cyber Threats Boost Demand Reddit Stock Ignites: Surge in Call Options Signals Big Bet Microsoft Stock Holds Steady as AI Drives Workforce Shift Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
